Advanced Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases
Authors:
- Rafaela FerrãoRFRafaela Ferrão
- Akhilesh RaiARAkhilesh Rai
- 19 July 2024
- book chapter
- Published by Wiley
- p. 843-885
Abstract
No abstract availableThis publication has 186 references indexed in Scilit:
- Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug ReleaseAdvanced Science, 2021
- From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain BarrierAdvanced Therapeutics, 2020
- Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological DiseasesAdvanced Materials, 2018
- Current understanding of Alzheimer’s disease diagnosis and treatmentF1000Research, 2018
- Effect of Deutetrabenazine on Chorea Among Patients With Huntington DiseaseJAMA, 2016
- Traceable Nanoparticle Delivery of Small Interfering RNA and Retinoic Acid with Temporally Release Ability to Control Neural Stem Cell Differentiation for Alzheimer's Disease TherapyAdvanced Materials, 2016
- Prediction of brain age suggests accelerated atrophy after traumatic brain injuryAnnals of Neurology, 2015
- Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier PermeationAdvanced Functional Materials, 2014
- The effect of selegiline in the treatment of people with Alzheimer's disease: a meta‐analysis of published trialsInternational Journal of Geriatric Psychiatry, 2002
- Permeability of the blood‐brain barrier induced by 915 MHz electromagnetic radiation, continuous wave and modulated at 8, 16, 50, and 200 HzMicroscopy Research and Technique, 1994